Literature DB >> 25300573

Enhanced expression of retinoic acid receptor alpha (RARA) induces epithelial-to-mesenchymal transition and disruption of mammary acinar structures.

Ayano Doi1, Kosuke Ishikawa2, Nao Shibata3, Emi Ito4, Jiro Fujimoto5, Mizuki Yamamoto3, Hatsuki Shiga6, Hiromi Mochizuki6, Yoshifumi Kawamura6, Naoki Goshima7, Kentaro Semba8, Shinya Watanabe4.   

Abstract

The early steps of mammary tumorigenesis include loss of epithelial cell polarity, escape from anoikis, and acquisition of proliferative capacity. The genes responsible for these processes are predicted to be early diagnostic markers or new therapeutic targets. Here we tested 51 genes coamplified with ERBB2 in the 17q12-21 amplicon for these tumorigenic activities using an MCF10A 3D culture-based screening system. We found that overexpression of retinoic acid receptor α (RARA) disrupted normal acinar structure and induced epithelial-to-mesenchymal transition (EMT). The mRNA levels of known EMT-inducing factors, including SLUG, FOXC2, ZEB1, and ZEB2, were significantly increased upon RARA overexpression. Knockdown of ZEB1 suppressed the RARA-mediated EMT phenotype. These results suggest that overexpression of RARA enhances malignant transformation during mammary tumorigenesis.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  3D culture; Breast cancer; EMT; ERBB2; Gene amplification; RARA

Mesh:

Substances:

Year:  2014        PMID: 25300573      PMCID: PMC5528664          DOI: 10.1016/j.molonc.2014.09.005

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  42 in total

1.  Expression screening of 17q12-21 amplicon reveals GRB7 as an ERBB2-dependent oncogene.

Authors:  Makoto Saito; Yukiko Kato; Emi Ito; Jiro Fujimoto; Kosuke Ishikawa; Ayano Doi; Kentaro Kumazawa; Atsuka Matsui; Shiori Takebe; Takaomi Ishida; Sakura Azuma; Hiromi Mochizuki; Yoshifumi Kawamura; Yuka Yanagisawa; Reiko Honma; Jun-ichi Imai; Hirokazu Ohbayashi; Naoki Goshima; Kentaro Semba; Shinya Watanabe
Journal:  FEBS Lett       Date:  2012-05-11       Impact factor: 4.124

2.  Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARA.

Authors:  G Paroni; M Fratelli; G Gardini; C Bassano; M Flora; A Zanetti; V Guarnaccia; P Ubezio; F Centritto; M Terao; E Garattini
Journal:  Oncogene       Date:  2011-11-07       Impact factor: 9.867

3.  Co-amplification of erbB2, topoisomerase II alpha and retinoic acid receptor alpha genes in breast cancer and allelic loss at topoisomerase I on chromosome 20.

Authors:  W N Keith; F Douglas; G C Wishart; H M McCallum; W D George; S B Kaye; R Brown
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

Review 4.  Untangling the ErbB signalling network.

Authors:  Y Yarden; M X Sliwkowski
Journal:  Nat Rev Mol Cell Biol       Date:  2001-02       Impact factor: 94.444

5.  Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer.

Authors:  I Bièche; C Tomasetto; C H Régnier; C Moog-Lutz; M C Rio; R Lidereau
Journal:  Cancer Res       Date:  1996-09-01       Impact factor: 12.701

6.  RNA interference-based functional dissection of the 17q12 amplicon in breast cancer reveals contribution of coamplified genes.

Authors:  Jessica Kao; Jonathan R Pollack
Journal:  Genes Chromosomes Cancer       Date:  2006-08       Impact factor: 5.006

Review 7.  Modeling tissue morphogenesis and cancer in 3D.

Authors:  Kenneth M Yamada; Edna Cukierman
Journal:  Cell       Date:  2007-08-24       Impact factor: 41.582

8.  RARalpha antagonist Ro 41-5253 inhibits proliferation and induces apoptosis in breast-cancer cell lines.

Authors:  S Toma; L Isnardi; P Raffo; L Riccardi; G Dastoli; C Apfel; P LeMotte; W Bollag
Journal:  Int J Cancer       Date:  1998-09-25       Impact factor: 7.396

9.  The epithelial-mesenchymal transition generates cells with properties of stem cells.

Authors:  Sendurai A Mani; Wenjun Guo; Mai-Jing Liao; Elinor Ng Eaton; Ayyakkannu Ayyanan; Alicia Y Zhou; Mary Brooks; Ferenc Reinhard; Cheng Cheng Zhang; Michail Shipitsin; Lauren L Campbell; Kornelia Polyak; Cathrin Brisken; Jing Yang; Robert A Weinberg
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

10.  A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk.

Authors:  E Katz; S Dubois-Marshall; A H Sims; D Faratian; J Li; E S Smith; J A Quinn; M Edward; R R Meehan; E E Evans; S P Langdon; D J Harrison
Journal:  Br J Cancer       Date:  2010-07-13       Impact factor: 7.640

View more
  17 in total

1.  Flaxseed and its components differentially affect estrogen targets in pre-neoplastic hen ovaries.

Authors:  Anushka Dikshit; Chunqi Gao; Carrie Small; Karen Hales; Dale Buchanan Hales
Journal:  J Steroid Biochem Mol Biol       Date:  2016-02-27       Impact factor: 4.292

2.  All-trans-retinoic Acid Modulates the Plasticity and Inhibits the Motility of Breast Cancer Cells: ROLE OF NOTCH1 AND TRANSFORMING GROWTH FACTOR (TGFβ).

Authors:  Adriana Zanetti; Roberta Affatato; Floriana Centritto; Maddalena Fratelli; Mami Kurosaki; Maria Monica Barzago; Marco Bolis; Mineko Terao; Enrico Garattini; Gabriela Paroni
Journal:  J Biol Chem       Date:  2015-05-27       Impact factor: 5.157

3.  An in vivo screening system to identify tumorigenic genes.

Authors:  T Ihara; Y Hosokawa; K Kumazawa; K Ishikawa; J Fujimoto; M Yamamoto; T Muramkami; N Goshima; E Ito; S Watanabe; K Semba
Journal:  Oncogene       Date:  2016-10-03       Impact factor: 9.867

4.  Pan-cancer analyses of the nuclear receptor superfamily.

Authors:  Mark D Long; Moray J Campbell
Journal:  Nucl Receptor Res       Date:  2015-12-15

5.  Enhanced expression of retinoic acid receptor alpha (RARA) induces epithelial-to-mesenchymal transition and disruption of mammary acinar structures.

Authors:  Ayano Doi; Kosuke Ishikawa; Nao Shibata; Emi Ito; Jiro Fujimoto; Mizuki Yamamoto; Hatsuki Shiga; Hiromi Mochizuki; Yoshifumi Kawamura; Naoki Goshima; Kentaro Semba; Shinya Watanabe
Journal:  Mol Oncol       Date:  2014-09-22       Impact factor: 6.603

6.  The cell competition-based high-throughput screening identifies small compounds that promote the elimination of RasV12-transformed cells from epithelia.

Authors:  Hajime Yamauchi; Takanori Matsumaru; Tomoko Morita; Susumu Ishikawa; Katsumi Maenaka; Ichigaku Takigawa; Kentaro Semba; Shunsuke Kon; Yasuyuki Fujita
Journal:  Sci Rep       Date:  2015-10-20       Impact factor: 4.379

7.  Positive feedback loop of IL-1β/Akt/RARα/Akt signaling mediates oncogenic property of RARα in gastric carcinoma.

Authors:  Hong-Yue Ren; Fan Liu; Gui-Li Huang; Yu Liu; Jin-Xing Shen; Pan Zhou; Wen-Ming Liu; Dong-Yan Shen
Journal:  Oncotarget       Date:  2017-01-24

8.  A method of producing genetically manipulated mouse mammary gland.

Authors:  Hiroaki Tagaya; Kosuke Ishikawa; Yoshito Hosokawa; Shun Kobayashi; Yukino Ueoka; Mayuna Shimada; Yasuko Ohashi; Hirofumi Mikami; Mizuki Yamamoto; Tatsuya Ihara; Kentaro Kumazawa; Kosuke Sugihara; Naoki Goshima; Shinya Watanabe; Kentaro Semba
Journal:  Breast Cancer Res       Date:  2019-01-05       Impact factor: 6.466

9.  Differential gene expression identifies a transcriptional regulatory network involving ER-alpha and PITX1 in invasive epithelial ovarian cancer.

Authors:  Yichao Li; Sushil K Jaiswal; Rupleen Kaur; Dana Alsaadi; Xiaoyu Liang; Frank Drews; Julie A DeLoia; Thomas Krivak; Hanna M Petrykowska; Valer Gotea; Lonnie Welch; Laura Elnitski
Journal:  BMC Cancer       Date:  2021-07-03       Impact factor: 4.430

10.  Mining for Candidate Genes Related to Pancreatic Cancer Using Protein-Protein Interactions and a Shortest Path Approach.

Authors:  Fei Yuan; Yu-Hang Zhang; Sibao Wan; ShaoPeng Wang; Xiang-Yin Kong
Journal:  Biomed Res Int       Date:  2015-11-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.